Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07436351 · ClinicalTrials.gov registry record · NA
ACT With CF Self-Help Toolkit
A NA study of Cystic Fibrosis (CF) and Depressive and Anxiety Disorders, sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07436351 is a NA study of Cystic Fibrosis (CF) and Depressive and Anxiety Disorders that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 60 participants, below the 137-participant average among 14 other Cystic Fibrosis (CF) trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07436351, a NA study of Cystic Fibrosis (CF) and Depressive and Anxiety Disorders, is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Acceptance and Commitment Therapy (ACT) tailored to meet the needs of adults living with cystic fibrosis (ACT with CF) is a newer form of talk therapy that has been shown to reduce anxiety \& depression and improve psychological flexibility, and value-based living. The investigators are now trying to find out whether a self-help version of this treatment (ACT with CF - Self Help Toolkit) is also effective in reducing anxiety and depression and improving psychological flexibility and value-based living in adults with CF. Adults with cystic fibrosis are at increased risk for anxiety and depression. This study examines whether a patient-facing therapy, ACT with CF - Self Help Toolkit can help to reduce anxiety and depression among adults with CF. This treatment can be accessed on the participant's smartphone.
Conditions Studied
Interventions
- BEHAVIORAL ACT with CF Self-Help Toolkit
- OTHER Waitlist
Study Locations (1)
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-01-20 |
| Est. Completion | 2027-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07436351
The ClinicalTrials.gov registry entry for NCT07436351 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 137-participant average among 14 other Cystic Fibrosis (CF) trials with a reported enrollment target (56% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cystic Fibrosis (CF) appearing as the primary indexed condition, and to 2 interventions - of which ACT with CF Self-Help Toolkit is the first listed.
NCT07436351 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07436351 about?
NCT07436351 is a clinical study titled "ACT With CF Self-Help Toolkit". Acceptance and Commitment Therapy (ACT) tailored to meet the needs of adults living with cystic fibrosis (ACT with CF) is a newer form of talk therapy that has been shown to reduce anxiety \& depression and improve psychological flexibility, and value-based living. The investigators are now trying t...
What is the current status of trial NCT07436351?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-01-20. Estimated completion is 2027-04.
What conditions does trial NCT07436351 study?
This clinical trial studies the following conditions: Cystic Fibrosis (CF), Depressive and Anxiety Disorders, Psychological Flexibility.
What interventions are being tested in trial NCT07436351?
The interventions under investigation include: ACT with CF Self-Help Toolkit (BEHAVIORAL), Waitlist (OTHER).
Who is sponsoring clinical trial NCT07436351?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07436351 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis (CF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Personalized Mobile Health Platform to Promote Physical Activity in Adolescents and Young Adults With Cystic Fibrosis
RECRUITING · NA
-
CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis
RECRUITING · NA
-
CF Wellness Program
RECRUITING · NA
-
OnTrackCF: Engagement, Feasibility, and Acceptability Study
RECRUITING · NA
-
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
RECRUITING
-
Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy
RECRUITING · Phase 3
Explore more on PlainTrial
Cystic Fibrosis (CF)
All registered trials for this condition
Depressive and Anxiety Disorders
All registered trials for this condition
Pennsylvania
All trials with a study site in Pennsylvania
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.